Naar inhoud
Rijksinstituut voor Volksgezondheid en Milieu

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours | RIVM

Jaar: 2022
Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours | RIVM